Our in vivo and in vitro studies using ω-3 fatty acids (FA) have provided insight into the biological effects and mechanisms of their anti-inflammatory action(s). The implications for this research are profound because there are few nutritional therapies available that have the potential to be clinically effective in malignancies and other chronic inflammatory conditions as ω-3 FA. In this summary of experiments the biological effects of ω-3 FA are discussed and the potential mechanisms of action presented.
Get full access to this article
View all access options for this article.
References
1.
Von SchackyC. Prophylaxis of atherosclerosis with marine ω-3 fatty acids, a comprehensive strategy. Ann Intern Med1987; 107:890.
2.
BeckSA, SmithKL, TisdaleMJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res1991;51:6089–93.
3.
TisdaleMJ, DhesiJK. Inhibition of weight loss by ω-3 fatty acids in an experimental cachexia model. Cancer Res1990;50:5022.
4.
BarberMD, RossJA, PrestonT, . Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr1999;129:1120.
5.
Mukutmoni-NorrisM, HubbardNE, EricksonKL. Modulation of murine mammary tumor vasculature by dietary n-3 fatty acids in fish oil. Cancer Lett2000;150:101–9.
6.
LoCJ, ChiuKC, FuM, . Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF-κB activity. J Surg Res1999;82:216–21.
7.
ObataT, NagakuraT, MasakiT, . Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclooxygenase-2 in cultured human mast cells. Clin Exp Allergy1999;29:1129–35.
8.
EspatNJ, BodeBP, LindDS, . Normalization of tumor-induced increases in hepatic amino acid transport after surgical resection. Ann Surg1995;221:50–8.
9.
KaibaraA, EspatNJ, AuffenbergT, . Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis. Cytokine1998;10:452–6.
10.
ChenMK, EspatNJ, BlandKI, CopelandEM3rd, SoubaWW. Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney. Ann Surg1993;217:655–66.
11.
EspatNJ, CopelandEM, SoubaWW. Accelerated hepatic arginine transport in the tumor-bearing rat. Ann Surg Oncol1994; 1:147–56.
12.
SoubaWW, StrebelFR, BullJM, CopelandEM, . Interorgan glutamine metabolism in the tumor-bearing rat. J Surg Res1988;44:720–6.
13.
InoueY, BodeBP, SoubaWW. Dietary regulation of the hepatic system in glutamine transporter in tumor-bearing rats. Am J Surg1995;169:173–8.
14.
MukutmoniM, HubbardNE, EricksonKL. Prostaglandin E(2) modulation of vascular endothelial growth factor production in murine macrophages. Prostaglandins Leukot Essent Fatty Acids2001;65:123–31.
15.
HoblerSC, WangJJ, WilliamsAB, . Sepsis is associated with increased ubiquitin-conjugating enzyme E2–14k mRNA in skeletal muscle. Am J Physiol1999;276(2 Pt 2):R468–73.
16.
BaracosVE, DeVivoC, HoyleDH, GoldvergAL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol1995;268(5 Pt 1):E996–1006.
17.
HoblerSC, WilliamsA, FischerD, . Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. Am J Physiol1999;277(2 Pt 2):R434–40.
18.
MalkowskiMG, ThuressonED, LakkidesKM, . Structure of eicosapentaenoic acid and linoleic acids in the cyclooxy-genase site of prostaglandin endoperoxide H synthase-1. J Biol Chem2001;270:37547–55.
